Document Detail


Development and reversal of contingent inefficacy and tolerance to the anticonvulsant effects of carbamazepine.
MedLine Citation:
PMID:  1985824     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The relationship of the timing of drug administration to anticonvulsant efficacy against amygdala kindled seizures was studied. During kindling development, rats received carbamazepine (CBZ, 15mg/kg) before (CBZ-before) or after each amygdala stimulation (CBZ-after). After kindling to full seizures, when all animals were given CBZ before the stimulation, only the CBZ-after group showed a good anticonvulsant response. The rats that had received CBZ before (during development of kindled seizures) remained unresponsive to CBZ treatment (contingent inefficacy). When drug-naive or CBZ-after animals repeatedly received CBZ before electrical stimulation, they developed tolerance to its anticonvulsant effects (contingent tolerance). The tolerance could be reversed by a period of treatment with CBZ-after or by kindling the animal drug-free, but not by CBZ administration alone or by time off from both drug and seizures. These findings suggest that inefficacy and tolerance to CBZ may be affected by the temporal contingencies of drug administration and that responsiveness can be reinstated by altering these contingencies.
Authors:
S R Weiss; R M Post
Related Documents :
21575744 - The importance of assessing medication exposure to the definition of refractory disease...
23640554 - Tuberculosis: from an incurable scourge to a curable disease - journey over a millennium.
23404394 - In vitro, in vivo and in silico models of drug distribution into the brain.
19004924 - Patterns of antiepileptic drug overdose differ between men and women: admissions to the...
8920124 - Determination of tetracyclines in animal feeds in the presence of other drugs by thin-l...
23584814 - The influence of stress on the transition from drug use to addiction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Epilepsia     Volume:  32     ISSN:  0013-9580     ISO Abbreviation:  Epilepsia     Publication Date:    1991 Jan-Feb
Date Detail:
Created Date:  1991-02-11     Completed Date:  1991-02-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2983306R     Medline TA:  Epilepsia     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  140-5     Citation Subset:  IM    
Affiliation:
Biological Psychiatry Branch, National Institute of Mental Health, Bethesda, Maryland 20892.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amygdala / drug effects,  physiology*
Animals
Carbamazepine / administration & dosage,  pharmacology*
Drug Tolerance
Electric Stimulation
Injections, Intraperitoneal
Kindling, Neurologic / drug effects*,  physiology
Male
Models, Neurological
Rats
Rats, Inbred Strains
Seizures / etiology,  prevention & control*
Time Factors
Chemical
Reg. No./Substance:
298-46-4/Carbamazepine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Double-blind, placebo-controlled, cross-over trial of progabide as add-on therapy in epileptic patie...
Next Document:  Alterations in the renal excretion of valproate and its metabolites after chronic treatment.